e-learning
resources
Barcelona 2022
05.09.2022
Epidemiological assessments and public health studies on tuberculosis and NTM
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of nontuberculous mycobacteria species on non-cancer mortality in patients with nontuberculous mycobacterial lung disease
C. Shu (Taipei, Taiwan), P. Wang (TNew New Taipei City, Taiwan), C. Chang (Taipei, Taiwan)
Source:
International Congress 2022 – Epidemiological assessments and public health studies on tuberculosis and NTM
Session:
Epidemiological assessments and public health studies on tuberculosis and NTM
Session type:
Thematic Poster
Number:
1897
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Shu (Taipei, Taiwan), P. Wang (TNew New Taipei City, Taiwan), C. Chang (Taipei, Taiwan). The impact of nontuberculous mycobacteria species on non-cancer mortality in patients with nontuberculous mycobacterial lung disease. 1897
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept